Diazepam induced sleep spindle increase correlates with cognitive recovery in a child with epileptic encephalopathy

S M Stoyell1, B S Baxter2,3, J McLaren1

  • 1Department of Neurology, Massachusetts General Hospital, 175 Cambridge St, Suite 340, Boston, MA, 02114, USA.

BMC Neurology
|September 15, 2021
PubMed

Insights

Continuous spike and wave of sleep (CSWS) is a severe epileptic encephalopathy. Treatment improved sleep spindles and cognitive function, suggesting spindles may be a biomarker and therapeutic target.

Area of Science:

  • Neuroscience
  • Epileptology
  • Sleep Medicine

Background:

  • Continuous spike and wave of sleep with encephalopathy (CSWS) is a rare epileptic encephalopathy linked to cognitive regression.
  • Thalamocortical circuit dysfunction is implicated in CSWS, but the cause of cognitive symptoms remains unclear.
  • Sleep spindles, generated by thalamocortical circuits, are crucial for memory consolidation and may be affected in CSWS.

Observation:

  • A longitudinal case study of a child with CSWS experiencing cognitive regression.
  • Electroencephalograms and neuropsychological evaluations were analyzed using automated detection algorithms.
  • The study tracked changes in epileptiform discharges and sleep spindles during treatment.

Findings:

  • High-dose diazepam treatment led to a significant increase in sleep spindles.
  • This increase in sleep spindles correlated with marked improvements in cognitive performance.
  • Sleep spindle rate was inversely correlated with spike rate, supporting shared thalamocortical circuitry.

Implications:

  • This case highlights thalamocortical circuit dysfunction in epileptic encephalopathy.
  • Sleep spindles show potential as a biomarker for cognitive function in CSWS.
  • Sleep spindles may represent a future therapeutic target for cognitive deficits in epileptic encephalopathies.
Abstract

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
517
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
240
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
809
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
364
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
370
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
439